Cannabidiol, also known as CBD, has been a topic of interest namely for its reputation of reducing chronic pain, inflammation, and discomfort. CBD is derived from a marijuana plant with at least 112 other unique chemical compounds, referred to as cannabinoids. Along with CBD, the other most commonly known cannabinoid is tetrahydrocannabinol, or THC, well known for its psychoactive properties that leave consumers with a “high” feeling. CBD, however, doesn’t produce these same “high” affects, so its addictive risk substantially decreases, therefore increasing its appeal in the medical field. #CBD #cannbidiol #research #fundingRead More
Science Market Update
Biotech scientists at the University of California, Berkeley received $12.3 million from the Department of Energy's Biological and Environmental Research Program. The researchers aim to develop an in-depth understanding of drought tolerance in field-grown sorghum.Read More
The Human Computation Institute, in collaboration with UC Berkeley and other institutions, has developed a new game called Stall Catchers that will allow the public to directly contribute to research for a cure to Alzheimer's disease. In the online game, participants will view movies of real blood vessels in mouse brains and search for any clogged capillaries, or stalls. Capillary stalls, where blood is no longer flowing, are thought to be a key cause of Alzheimer's disease.
The University of California, Berkeley is a leading research institution, producing promising research in all divsions of the life sciences. To help further research in immunotherapy and cancer, researchers from the University of California, Berkeley have recently teamed up with the Berkeley-based biotech company, Aduro Biotech Inc., for a $7.5 million immunotherapy initiative. This Immunotherapeutics and Vaccine Research Initiative (IVRI) will provide three years of funding to infectious disease researchers studying new techniques for combating both infections and cancer.Read More
Each year in the United States, more than 2 million people develop antibiotic-resistant infections and at least 23,000 people die as a result, according to the U.S. Centers for Disease Control and Prevention.Read More
Researchers at University of California, Berkeley have been doing a lot of bird watching lately to help understand the spread of infectious disease. In a recent study they found that Lyme disease, which many believe is spread by rodents and small mammals, is in fact regularly transmitted by several species of birds as well.Read More
The Environmental Protection Agency limits the amount of arsenic in U.S. public drinking water to 10 parts per billion (ppb). Water that comes from privately owned wells may contain higher levels of arsenic, especially in areas where the groundwater flows over arsenic-rich bedrock. In a recent study done by UC Berkeley, arsenic was found to potentially show benefits as a cancer fighting agent.
Emmanuelle Charpentier, Ph.D., and Jennifer A. Doudna, Ph.D., have been awarded the 2015 Breakthrough Prize in Life Sciences for their work in developing the CRISPR/Cas9 genome editing tool. Dr. Charpentier is the head of the Regulation in Infection Biology department at the Helmholtz-Zentrum für Infektionsforschung (Helmholtz Centre for Infection Research) in Braunschweig, Germany, and also a co-founder and advisor to Swiss drug developer CRISPR Therapeutics.Read More
The $500,000 Keck Fund research award was given earlier this year to bioengineering professors Kumar and Murthy for their project, Single Tumor Cell Proteomics for Diagnosis and Prognosis.
Remember life as a starving student? How about grad school? How about your post doctoral fellowship?
Tags: 2014, University of Michigan Ann Arbor, BioResearch Product Faire Event, Life Science Event, Biotechnology Vendor Showcase, UC Riverside, UC San Francisco, UC Davis - Medical Center, UC Berkeley, UC Irvine, post doc, salary, UC Los Angeles